Novozymes and Chr. Hansen have officially merged to form Novonesis, marking the largest merger in Danish history. This powerful collaboration combines over a century of innovation and expertise, positioning Novonesis as a global leader dedicated to tackling some of humanity's most pressing challenges through biological solutions.
A highlight of this merger is the formation of the Novonesis human health division, which stands out in the biosolutions landscape with its unique Strain to Solution™ approach. This capability allows Novonesis to partner with customers from the initial stages of product ideation all the way to shelf-ready products.
This merger will not only enhance Novonesis' capabilities but also expand it's impact on global health and well-being. Read more inside! | 
